ÂÜÀòÂÒÂ×

Omri Amirav-Drory is a distinguished professional in the biochemistry and biotechnology sectors, currently serving as a Board Member for multiple organizations, including Radar Therapeutics, TwoStep Therapeutics, ZipBio, Centivax, Talus Bio, Mana.bio, La Jolla Labs, PANGEA Therapeutics, and Pepper Bio. As the Founder and CEO of Renewal Bio since May 2022, Omri Amirav-Drory focuses on advancing human health. Omri Amirav-Drory holds a Postdoctoral degree in Biochemistry and Molecular Biology from Stanford University and a Ph.D. in Biochemistry, alongside a Bachelor of Science from Tel Aviv University.